Repair of acute respiratory distress syndrome by stromal cell administration (realist): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial

HIGHLIGHTS

• who: Ellen Gorman from the Medicine, Queenu2019s University, BelfastBelfast, UK have published the research work: Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial, in the Journal: (JOURNAL) of 20/04/2020
• what: This trial investigates a novel CD362 enriched umbilical cord derived MSC product (REALIST ORBCEL-C) produced to Good Manufacturing Practice standards in patients with moderate to severe ARDS due to COVID-19 and ARDS . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.